Nazwa produktu: |
ALA-pro-gli-(ILE3,VAL5)-angiotensyna II |
Synonimy |
Crinia-angiotensyna; Ala-pro-gly-(3-ile-5-val)-angiotensyna II;Angiotensyna II, ala-pro-gly-(ile(3)-val(5))-; angiotensyna II, alanylo-prolilo-glicylo-(izoleucylo(3)-walina(5))-; L-fenyloalanina, N-(1-(N-(N-(N-(N-(N-(N(2)-(N-(N-(1-L-alanylo-L-prolilo)glicylo)-L-alfa-asparatylo)-L-arginylo)-L-izoleucylo)-L-tyrozylo)-L-walyl)-L-histydylo)-L-prolil)-; L-alanylo-L-proliloglicylo-L-alfa-asparatylo-N~5~-(diaminometyliden)-L-ornitylo-L-izoleucylo-L-tyrozylo-L-valyl-3-(4H-imidazol-4-ylo)-L-alanylo-L-prolilo-L-fenyloalanina; Ala-Pro-Gly-Asp-Arg-Ile-Tyr-Val-His-Pro-Phe |
Angielska nazwa |
ala-pro-gly-(ile3,val5)-angiotensin ii;Crinia-angiotensin; Ala-pro-gly-(3-ile-5-val)-angiotensin II; Angiotensin II, ala-pro-gly-(ile(3)-val(5))-; Angiotensin II, alanyl-prolyl-glycyl-(isoleucyl(3)-valine(5))-; L-Phenylalanine, N-(1-(N-(N-(N-(N-(N(2)-(N-(N-(1-L-alanyl-L-prolyl)glycyl)-L-alpha-aspartyl)-L-arginyl)-L-isoleucyl)-L-tyrosyl)-L-valyl)-L-histidyl)-L-prolyl)-; L-alanyl-L-prolylglycyl-L-alpha-aspartyl-N~5~-(diaminomethylidene)-L-ornithyl-L-isoleucyl-L-tyrosyl-L-valyl-3-(4H-imidazol-4-yl)-L-alanyl-L-prolyl-L-phenylalanine; Ala-Pro-Gly-Asp-Arg-Ile-Tyr-Val-His-Pro-Phe |
MF |
C60H86N16O15 |
Masie cząsteczkowej |
1271.423 |
InChI |
InChI=1/C60H86N16O15/c1-6-33(4)49(74-50(81)39(15-10-22-65-60(62)63)69-51(82)41(28-47(79)80)68-46(78)30-66-53(84)44-16-11-23-75(44)57(88)34(5)61)56(87)70-40(25-36-18-20-38(77)21-19-36)52(83)73-48(32(2)3)55(86)71-42(27-37-29-64-31-67-37)58(89)76-24-12-17-45(76)54(85)72-43(59(90)91)26-35-13-8-7-9-14-35/h7-9,13-14,18-21,29,31-34,37,39-45,48-49,77H,6,10-12,15-17,22-28,30,61H2,1-5H3,(H,66,84)(H,68,78)(H,69,82)(H,70,87)(H,71,86)(H,72,85)(H,73,83)(H,74,81)(H,79,80)(H,90,91)(H4,62,63,65)/t33-,34-,37?,39-,40-,41-,42-,43-,44-,45-,48-,49-/m0/s1 |
Nr CAS |
72007-47-7 |
Struktury molekularnej |
|
Gęstość |
1.46g/cm3 |
Współczynnik załamania |
1.672 |
Symbole zagrożenia |
|
Kody ryzyka |
|
Bezpieczeństwo opis |
|
|